Arkolith/Insider Trading/APGE/Form 4

Henderson Michael Thomas

Chief Executive Officer, DirectorApogee Therapeutics, Inc. (APGE) · full profile →Form 4 · filed Mar 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.5M
Net Open-Market Flow
-$1.5M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 11, 2026Sell(S)3K$75.86$259K1.2M
Mar 11, 2026Sell(S)8K$74.83$615K1.2M
Mar 11, 2026Sell(S)8K$74.29$621K1.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-027802) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML